Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients

Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients

Background We investigated the long-term efficacy and safety of initial triple therapy using metformin, a dipeptidyl peptidase-4 inhibitor, and a sodium-glucose cotransporter-2 inhibitor, in patients with type 2 diabetes mellitus. Methods We enrolled 170 drug-naïve patients with glycosylated hemoglo...

Full description

Bibliographic Details
Main Authors: Young-Hwan Park, Minji Sohn, So Yeon Lee, Soo Lim
Format: Article
Language:English
Published: Korean Diabetes Association 2024-03-01
Series:Diabetes & Metabolism Journal
Subjects:
dipeptidyl-peptidase iv inhibitors
glycated hemoglobin
sodium-glucose transporter 2 inhibitors
Online Access:http://e-dmj.org/upload/pdf/dmj-2023-0128.pdf

Similar Items

Similar Items